Strategic Advisory Board - Patient Focused Medicines Development

PFMD Strategic Advisory Board

Daniel De Schryver
Patient Engagement & Advocacy Lead, EMEA at Janssen Pharmaceuticals
Kelly Donlon Hoy
Internal Communication and Employee Engagement Consultant at Merck
Eleanor Perfetto
Executive Vice President at National Health Council
Helen Sivey
Public Involvement Officer at the NHS Health Research Authority
Michaela Dinboeck
Senior Director, Group Patient Advocacy & Communications at Novartis
Rosamund Round
Vice President, Patient Innovation Center at Parexel
Natasha Ratcliffe
Research Involvement Manager at Parkinson’s UK
Karlin Schroeder
Senior Director, Community Engagement at Parkinson’s Foundation
Phillips Berkeley
Medical Director at Pfizer
Stephanie Ludwig
Global Patient Partnership Chapter Lead- Neuroscience at Roche
Marie-Jeanne Pierrat
Scientific Project Leader at Servier
Laura Evans
Patient and Public Involvement and Communications Lead for the NIHR Sheffield Biomedical Research Centre
Jessica Scott
Head of R & D Patient Engagement at Takeda
Nim Lalvani
Executive Director at The American Migraine Foundation
Sheila Khawaja
Vice Chair at WAPO
Muriël Marks
Executive Director at WAPO
Guy Eakin
Senior Vice President, Scientific Strategy at Arthritis Foundation
Douglas Noland
Head of Patient Experience, Executive Director at Astellas
Sarah Krug
Executive Director at Cancer101
Debra Michaels
Associate Director, Scientific Programs at DIA
Laure Delbecque
Research Scientist – Patient-Focused Outcomes at Eli Lilly and Company
Schiffon Wong
Executive Director, Global Evidence & Value Development at EMD Serono, Inc.
Yann Le Cam
Chief Executive Officer at EURORDIS
Geraldine Reilly
Global Patient Engagement Executive Director at Gilead Sciences
X